Pay in 4 interest-free payments of $6.19 Learn more
Ships within 48 hours · Estimated delivery Sep 24 - Sep 29
Exenatide and lixisenatide were demonstrated to cross the BBB, suggesting a significant advantage of these GLP-1 receptor agonists in search for a treatment for AD and PD [21]
Which naturally raises the question for biopharma investors and developers alike what therapeutic area could repeat this success
This has prompted the exploration of novel molecular strategies, including the use of peptides as therapeutic agents [49-53]
L- , : : , , , ,
US$ 25.40
US$ 27.54
US$ 24.73
US$ 26.60
US$ 25.01
US$ 20.72
US$ 26.16
US$ 29.56
US$ 21.48
US$ 24.95
US$ 27.94
US$ 26.67
US$ 29.83
US$ 23.29
